#BEGIN_DRUGCARD DB07716

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C22H30O8

# Chemical_IUPAC_Name:
(1R,3S,4R,5R,11S,13R,15S,17R,21S,22R,24S)-22-(hydroxymethyl)-2,6,12,16,23-pentaoxapentacyclo[13.11.0.0^{3,13}.0^{5,11}.0^{17,24}]hexacosa-8,19,25-triene-4,21-diol

# Chemical_Structure:
Not Available

# Creation_Date:
2010-09-15 15:25:11 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL

# HET_ID:
ENE

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C22H30O8/c23-11-19-12(24)4-3-6-13-14(28-19)7-8-15-17(27-13)10-18-22(30-15)20(25)21-16(29-18)5-1-2-9-26-21/h1-4,7-8,12-25H,5-6,9-11H2/b4-3-/t12-,13+,14-,15+,16-,17-,18+,19+,20+,21-,22+/m0/s1

# InChI_Key:
InChIKey=VDRIXSJOPKVWKM-HXGIDPQASA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
7722

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
422.4688

# Molecular_Weight_Mono:
422.194067936

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0.36

# Predicted_LogS:
-2.3

# Predicted_Water_Solubility:
2.19e+00 g/l

# Primary_Accession_No:
DB07716

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
45480632

# PubChem_Substance_ID:
99444187

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
[H][C@@]12C[C@]3([H])O[C@]4([H])C\C=C/[C@]([H])(O)[C@@]([H])(CO)O[C@@]4([H])C=C[C@@]3([H])O[C@@]1([H])[C@]([H])(O)[C@@]1([H])OCC=CC[C@]1([H])O2

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:25:58 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
2

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
J00241

# Drug_Target_1_GenBank_ID_Protein:
185945

# Drug_Target_1_GeneCard_ID:
IGKC

# Drug_Target_1_Gene_Name:
IGKC

# Drug_Target_1_Gene_Sequence:
Not Available

# Drug_Target_1_General_Function:
Involved in antigen binding

# Drug_Target_1_General_References:
4893682	Titani K, Shinoda T, Putnam FW: The amino acid sequence of a kappa type Bence-Jones protein. 3. The complete sequence and the location of the disulfide bridges. J Biol Chem. 1969 Jul 10;244(13):3550-60.
4923144	Gall WE, Edelman GM: The covalent structure of a human gamma G-immunoglobulin. X. Intrachain disulfide bonds. Biochemistry. 1970 Aug 4;9(16):3188-96.
5027703	Suter L, Barnikol HU, Watanabe S, Hilschmann N: [Rule of antibody structure. The primary structure of a monoclonal immunoglobulin L-chain of kappa-type, subgroup 3 (Bence-Jones protein Ti). IV. The complete amino acid sequence and its significance for the mechanism of antibody production] Hoppe Seylers Z Physiol Chem. 1972 Feb;353(2):189-208.
5447531	Kohler H, Shimizu A, Paul C, Putnam FW: Macroglobulin structure: variable sequence of light and heavy chains. Science. 1970 Jul 3;169(940):56-9.
5489770	Gottlieb PD, Cunningham BA, Rutishauser U, Edelman GM: The covalent structure of a human gamma G-immunoglobulin. VI. Amino acid sequence of the light chain. Biochemistry. 1970 Aug 4;9(16):3155-61.
5586923	Hilschmann N: [The complete amino acid sequence of Bence Jones protein Cum (kappa-type)] Hoppe Seylers Z Physiol Chem. 1967 Dec;348(12):1718-22.
6775818	Hieter PA, Max EE, Seidman JG, Maizel JV Jr, Leder P: Cloned human and mouse kappa immunoglobulin constant and J region genes conserve homology in functional segments. Cell. 1980 Nov;22(1 Pt 1):197-207.
9588180	Olsen KE, Sletten K, Westermark P: Extended analysis of AL-amyloid protein from abdominal wall subcutaneous fat biopsy: kappa IV immunoglobulin light chain. Biochem Biophys Res Commun. 1998 Apr 28;245(3):713-6.

# Drug_Target_1_HGNC_ID:
GNC:5716

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
6338

# Drug_Target_1_Locus:
2p12

# Drug_Target_1_Molecular_Weight:
11608.8

# Drug_Target_1_Name:
Ig kappa chain C region

# Drug_Target_1_Number_of_Residues:
106

# Drug_Target_1_PDB_ID:
1N8Z

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF07654	C1-set

# Drug_Target_1_Protein_Sequence:
>Ig kappa chain C region
TVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDS
KDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Not Available

# Drug_Target_1_SwissProt_ID:
P01834

# Drug_Target_1_SwissProt_Name:
IGKC_HUMAN

# Drug_Target_1_Synonyms:
Not Available

# Drug_Target_1_Theoretical_pI:
5.68

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB07716
